BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 12813632)

  • 1. [Pancreatic cancer--diagnostics and therapy].
    Schramm H
    Zentralbl Chir; 2003 May; 128(5):367. PubMed ID: 12813632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma.
    Brown ZJ; Cloyd JM
    J Surg Oncol; 2021 May; 123(6):1432-1440. PubMed ID: 33831253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
    Joensuu TK; Kiviluoto T; Kärkkäinen P; Vento P; Kivisaari L; Tenhunen M; Westberg R; Elomaa I
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):444-52. PubMed ID: 15380578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic carcinoma--overcome technically but not oncologically].
    Herfarth Ch
    Chirurg; 2003 Mar; 74(3):163-4. PubMed ID: 12722765
    [No Abstract]   [Full Text] [Related]  

  • 6. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
    Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
    Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma].
    Kopchak VM; Kopchak KV; Romaniv IaV
    Klin Khir; 2006 Feb; (2):23-5. PubMed ID: 16826811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients.
    Brunner TB; Tinkl D; Grabenbauer GG; Meyer T; Brueckl WM; Sauer R
    Strahlenther Onkol; 2006 Apr; 182(4):210-5. PubMed ID: 16622622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs in pancreatic cancer.
    Ducreux M; Boige V; Malka D
    Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
    Rocha Lima CM; Flores AM
    J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy and radiotherapy for inoperable pancreatic cancer. A survey of a Cochrane review].
    Bjerregaard JK; Pfeiffer P
    Ugeskr Laeger; 2007 Nov; 169(46):3949-52. PubMed ID: 18078646
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
    Wilkowski R; Thoma M; Weingandt H; Dühmke E; Heinemann V
    JOP; 2005 May; 6(3):216-30. PubMed ID: 15883472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.
    Cunningham SC; Cusnir M; Burdick RK; Van Echo DA; Moesinger R
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):741-2; discussion 743. PubMed ID: 16258479
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer. Breaching the cancer fortress.
    Olson P; Hanahan D
    Science; 2009 Jun; 324(5933):1400-1. PubMed ID: 19520948
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant therapy for pancreatic cancer: a time that has not yet come.
    Neifeld JP
    J Surg Oncol; 2007 Jun; 95(7):530-1. PubMed ID: 17192919
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosis of pancreatic adenocarcinoma].
    Escourrou J; Buscail L; Pages P; Moreau J; Faure P
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C30-3. PubMed ID: 11787377
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.
    Oztop I; Yilmaz U; Yavuzsen T; Yaren A; Tarhan O; Sagol O; Coker A; Alakavuklar M
    Chemotherapy; 2004 Jun; 50(3):127-32. PubMed ID: 15282439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104.
    Crane CH
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):1009; author reply 1009-10. PubMed ID: 14967465
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival for patients with pancreatic cancer after addition of gemcitabine to fluorouracil chemoradiation.
    Vikram B
    JAMA; 2008 Jun; 299(24):2852; author reply 2852-3. PubMed ID: 18577724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.